Production (Stage)
Amphastar Pharmaceuticals, Inc.
AMPH
$24.47
$0.271.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.44% | 4.97% | -17.86% | 45.26% | 65.86% |
| Total Depreciation and Amortization | 8.91% | 6.35% | 6.35% | 101.47% | 88.79% |
| Total Amortization of Deferred Charges | -64.19% | -75.15% | -85.79% | -23.64% | 3,506.78% |
| Total Other Non-Cash Items | 220.47% | -596.37% | 470.46% | -41.21% | -53.64% |
| Change in Net Operating Assets | -130.06% | 67.88% | -27.56% | 1.85% | -3,569.19% |
| Cash from Operations | -36.56% | 21.62% | -6.80% | 25.83% | 36.92% |
| Capital Expenditure | -21.65% | -31.44% | -35.32% | 33.24% | 7.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 74.24% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.87% | 75.14% | -35.18% | 4,906.99% | 664.31% |
| Cash from Investing | -31.21% | 65.38% | -11.02% | 86.26% | 340.60% |
| Total Debt Issued | -59.77% | -- | -97.24% | -100.01% | -- |
| Total Debt Repaid | 61.22% | 99.77% | 99.98% | 88.13% | 89.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 9.39% | -- | 36.61% | -- | -37.61% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.46% | 104.48% | 94.38% | 100.01% | -- |
| Cash from Financing | -6.80% | 28.12% | -126.34% | -102.50% | -0.23% |
| Foreign Exchange rate Adjustments | 221.65% | 95.38% | -65.79% | 13.64% | -706.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.17% | 67.98% | -97.91% | 54.91% | 177.10% |